A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome

Stefan Faderl, Farhad Ravandi, Xuelin Huang, Guillermo Garcia-Manero, Alessandra Ferrajoli, Zeev Estrov, Gautam Borthakur, Srdan Verstovsek, Deborah A. Thomas, Monica Kwari, Hagop M. Kantarjian

Research output: Contribution to journal › Article › peer-review

186 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry